Urogen Pharma Ltd. (URGN) SEC Filings — 2024

Filings

• Pontifax Amends UroGen Pharma Holdings Filing — SC 13D/A · Nov 18, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• Urogen Pharma Ltd. SC 13G Filing — SC 13G · Nov 12, 2024
• Urogen Pharma Ltd. SC 13G Filing — SC 13G · Nov 8, 2024
• UroGen Pharma Files 8-K on Financials — 8-K · Nov 6, 2024
• UroGen Pharma Q3 2024: Assets $42.2M, Liabilities $32.5M — 10-Q · Nov 6, 2024
• Urogen Pharma Ltd. SC 13G Filing — SC 13G · Nov 6, 2024
• Urogen Pharma Ltd. SC 13G Filing — SC 13G · Oct 24, 2024
• UroGen Pharma Appoints New CMO, Elects Directors — 8-K · Oct 9, 2024
• UroGen Pharma Ltd. Reports New Financial Obligation — 8-K · Sep 24, 2024
• UroGen Pharma Appoints New CMO and Board Member — 8-K · Sep 13, 2024
• UroGen Pharma to be Acquired by Foundry Acquisition — 8-K · Aug 15, 2024
• UroGen Pharma Files 8-K on Operations — 8-K · Aug 13, 2024
• UroGen Pharma Q2 2024: Assets $614K, Liabilities $65K — 10-Q · Aug 13, 2024
• UroGen Pharma Appoints New CMO, CCO, and Board Member — 8-K · Aug 8, 2024
• UroGen Pharma Shareholder Meeting: Director Elections & Equity Plan — DEF 14A · Jul 1, 2024
• Urogen Pharma Ltd. SC 13G Filing — SC 13G · Jun 24, 2024
• Urogen Pharma Ltd. SC 13G Filing — SC 13G · Jun 24, 2024
• UroGen Pharma Raises $100M in Public Offering — 8-K · Jun 18, 2024
• Deciphera to Acquire UroGen Pharma for $755M — 8-K · Jun 13, 2024
• UroGen Pharma Files 8-K for Operations and Financials — 8-K · May 13, 2024
• UroGen Pharma Ltd. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · May 8, 2024
• UroGen Pharma Ltd. Files 10-K/A Amendment for Fiscal Year Ended Dec 31, 2023 — 10-K/A · Apr 29, 2024
• UroGen Pharma Files 8-K for Financial Updates — 8-K · Mar 14, 2024
• UroGen Pharma Ltd. Files 2023 Annual Report on Form 10-K — 10-K · Mar 14, 2024
• UroGen Pharma Files 8-K — 8-K · Mar 4, 2024
• AbbVie to Acquire UroGen Pharma for $750M — 8-K · Mar 1, 2024
• Arkin Amends UroGen Pharma Stake Filing — SC 13D/A · Feb 22, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Urogen Pharma Ltd. SC 13G Filing — SC 13G · Feb 14, 2024
• Urogen Pharma Ltd. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• UroGen Pharma Files 8-K for Reg FD Disclosure, Exhibits — 8-K · Feb 7, 2024
• BlackRock Discloses Passive Stake in UroGen Pharma — SC 13G · Feb 2, 2024
• UroGen Pharma Enters Material Definitive Agreement — 8-K · Jan 17, 2024
• UroGen Pharma Enters Material Definitive Agreement on Dec 28 — 8-K · Jan 2, 2024